ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0169

Impact of Sense of Control Among People Living with SLE

Amanda Eudy1, S. Sam Lim2, Charmayne M. Dunlop-Thomas3, Jinoos Yazdany4, Patti Katz5 and Laura Plantinga6, 1Duke University, Raleigh, NC, 2Emory University, Atlanta, GA, 3Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA, 4University of California San Francisco, San Francisco, CA, 5UCSF, San Rafael, CA, 6University of California, San Francisco, San Francisco, CA

Meeting: ACR Convergence 2024

Keywords: quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 16, 2024

Title: Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: SLE is a disease characterized by cycles of remitting and relapsing symptoms that can be unpredictable, stressful, and cause an individual to feel they are unable to gain control over their life or their disease. We sought to determine the association of these feelings of sense of control (SoC) with work productivity and activities of daily living in a cohort of patients with SLE.

Methods: Individuals with SLE (ACR criteria confirmed by a rheumatologist) were recruited from an ongoing population-based cohort in metropolitan Atlanta. Participants completed a cross-sectional survey (10/2019-5/2022), which included the Learned Helplessness (LH) subscale of the Rheumatology Attitudes Index, Work Productivity and Activity Index, Basic Activities of Daily Living (ADL), Instrumental ADL, Systemic Lupus Activity Questionnaire (SLAQ), and the Brief Index of Lupus Damage (BILD). The LH subscale was used to characterize “sense of control” and includes 5 Likert-scale questions with a total score ranging from 5 to 25, with higher SoC scores indicating less sense of control. Generalized linear regression models estimated the association between SoC and continuous outcomes of interest. Multivariable logistic regression estimated the association of SoC and any difficulty in ADL. All models were adjusted for age, race, gender, and depression.

Results: The study included 429 participants with SLE; 92% female, 82% Black, 6% Hispanic, mean age 46 years, mean disease duration 16.5 years, 53% currently unemployed, 22% high school education or less, mean SLAQ: 12 (SD: 7.5). About 21-32% said they agreed or strongly agreed their condition is controlling their life, they would feel helpless if they could not rely on others for help, they cannot get relief from pain, and that fate and other factors beyond their control affect their condition (Figure 1). Overall, the average SoC score was 12.1 (SD: 4.6); scores were higher, indicating less SoC, for men, Black participants, participants with lower education, participants who were not employed, participants with higher patient-reported disease activity, and participants with more patient-reported SLE disease damage (Figure 2). Additionally, SoC scores were higher for participants with any work productivity impairment due to their health or participants with any difficulty performing basic or instrumental ADL (Figure 2). After adjustment, less SoC was associated with lower work productivity, with more time missed due to health (β: 1.08; 95% CI: 0.23, 1.94) and more impairment while working due to health (β: 2.78; 95% CI: 1.82, 3.73). Additionally, we observed greater odds of difficulty performing basic ADL (OR: 1.21; 95% CI: 1.14, 1.29) and instrumental ADL (OR: 1.21; 95% CI: 1.14, 1.29) with higher SoC scores.

Conclusion: We found that higher scores for SoC were more common in men and those who were Black, had lower educational attainment, or who had greater disease activity, indicating worse SoC in these participants. Further, higher SoC scores were associated with lower work productivity and lower ability to perform activities of daily living. Awareness of SoC in patients with SLE and support to improve SoC is essential to improving quality of life in this patient population.

Supporting image 1

Figure 1. Subscale of the Rheumatology Attitudes Index

Supporting image 2

Figure 2. Distribution of SoC scores by participant characteristics.

Supporting image 3

Figure 3. Distribution of SoC scores by work productivity and activities of daily living.


Disclosures: A. Eudy: Exagen, 5, GlaxoSmithKline, 5, Immunovant, 5; S. Lim: Accordant, 2, AstraZeneca, 2, Biogen, 5, BMS, 5, Gilead, 5, GSK, 2, Novartis, 5, UCB, 5; C. Dunlop-Thomas: None; J. Yazdany: AstraZeneca, 2, Aurinia, 5, Bristol-Myers Squibb(BMS), 5, Gilead, 5, UCB, 2; P. Katz: None; L. Plantinga: None.

To cite this abstract in AMA style:

Eudy A, Lim S, Dunlop-Thomas C, Yazdany J, Katz P, Plantinga L. Impact of Sense of Control Among People Living with SLE [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/impact-of-sense-of-control-among-people-living-with-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-sense-of-control-among-people-living-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology